M&A Deal Summary

Sharp Fluidics Acquires neoSurgical

On April 7, 2020, Sharp Fluidics acquired medical products company neoSurgical

Acquisition Highlights
  • This is Sharp Fluidics’ 1st transaction in the Medical Products sector.
  • This is Sharp Fluidics’ 1st transaction in the United States.
  • This is Sharp Fluidics’ 1st transaction in Massachusetts.

M&A Deal Summary

Date 2020-04-07
Target neoSurgical
Sector Medical Products
Buyer(s) Sharp Fluidics
Deal Type Add-on Acquisition

Target

neoSurgical

Newton, Massachusetts, United States
neoSurgical Ltd. is a commercial-stage company focused on being a global leader in the development of innovative surgical products. The company’s initial product is neoClose, approved for sale in the U.S. and Europe and designed to be the new standard for Lap surgery port site closure, a potential $300 million opportunity. neoSurgical was formed n 2007 anis based in Newton, Massachusetts.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Sharp Fluidics

Hayward, California, United States

Category Company
Sector Medical Products
DESCRIPTION

Sharp Fluidics LLC is a surgical device company that develops and markets innovative medical technologies and devices to improve surgical closure efficiency and safety.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2020 M&A 1 of 1